Conference topic: "New Translational Approaches in Cancer Therapy,"

International keynote speakers:
-Frances Balkwill (Barts Cancer Institute, UK)
- Nicholas McGranahan (University College London, UK) - EMBO Young Investigator
-Mara Sherman (Memorial Sloan Kettering Cancer Center, USA)
-Daniela Thommen (The Netherlands Cancer Institute, NL)
-Michael Schmück-Henneresse (Berlin Institute of Health, DE)
-Charles Herbaux (CHU de Montpellier, FR)
-Joanne Clancy (Nature Communications, UK)

Abstract submission: open only to students, postdocs, and junior clinicians. To submit your abstract, please follow the instructions on our website (https://www.crct-inserm.fr/en/ys2c_2024/). This year, we have a session for clinicians.

Key dates:
- oral presentation until July 12, 2024 (open to postdocs and clinicians)
- poster presentation until September 06, 2024 (open to PhD students, postdocs and clinicians)

Best oral communication prize: the winner will have free registration for the EACR annual conference. Other oral communication prizes will be announced soon.

Registration: open to everyone, free, but mandatory. Open until September 22, 2024.

Sponsored by: Canceropole GSO, SIRIC Montpellier, Boehringer Ingelheim Foundation, EMBO, ARC, Ligue contre le Cancer, SFC, University of Montpellier, 10X, G-clips, Thermofisher. We await funding from French-German University and other industrial partners.

Looking forward to seeing many of you soon in Montpellier,

 

Anna Salvioni, on behalf of the organizing committee.

More information:
Website:
https://www.crct-inserm.fr/en/ys2c_2024/
Get in touch:
Twitter/X:
https://x.com/Crct_Postdoc/
LinkedIn:
https://www.linkedin.com/posts/steffen-fuchs-md-m-sc-58b948165_montpellier-activity-7174895098449555456-XRm9